| Literature DB >> 33219130 |
Peng Lei1, Scott Ayton2, Ashley I Bush3.
Abstract
Treatments for Alzheimer's disease (AD) directed against the prominent amyloid plaque neuropathology are yet to be proved effective despite many phase 3 clinical trials. There are several other neurochemical abnormalities that occur in the AD brain that warrant renewed emphasis as potential therapeutic targets for this disease. Among those are the elementomic signatures of iron, copper, zinc, and selenium. Here, we review these essential elements of AD for their broad potential to contribute to Alzheimer's pathophysiology, and we also highlight more recent attempts to translate these findings into therapeutics. A reinspection of large bodies of discovery in the AD field, such as this, may inspire new thinking about pathogenesis and therapeutic targets.Entities:
Keywords: Alzheimer’s disease; PBT2; clioquinol; copper; ferroptosis; iron; selenium; zinc
Mesh:
Substances:
Year: 2020 PMID: 33219130 PMCID: PMC7948403 DOI: 10.1074/jbc.REV120.008207
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157